Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 257 of 5804
-
New drug aims to stop transplant complications in blood cancer patients
Disease control Not yet recruitingThis phase II trial studies how well adding axatilimab to standard of care (SOC) therapy works in preventing graft versus host disease (GVHD) following allogeneic hematopoietic stem cell transplantation (HCT) in patients with hematologic cancer. Allogeneic HCT is a procedure in w…
Phase: PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC
-
New hope for rare kidney cancer: drug trial targets tough tumors
Disease control Not yet recruitingTo learn if sacituzumab tirumotecan can help to control advanced or metastatic SMARCB1-deficient RMC in patients whose disease has progressed after receiving at least 1 treatment.
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Triple threat: new combo therapy targets Hard-to-Treat stomach cancer
Disease control Not yet recruitingThis study is a domestic, multicenter, single-arm clinical trial designed to evaluate the efficacy and safety of heterogeneous radiotherapy (high and low dose) sequenced with iparomlimab and tuvonralimab plus SOX as a first-line treatment for unresectable locally advanced or meta…
Phase: PHASE4 • Sponsor: Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 12:01 UTC
-
New procedure could help stroke patients whose symptoms worsen
Disease control Not yet recruitingThis multicenter, prospective, open-label randomized controlled trial with blinded assessment was designed to assess the efficacy and safety of endovascular treatment for progressive stroke due to vertebrobasilar artery occlusion.
Phase: NA • Sponsor: Feng Gao • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
Can ketamine plus therapy curb suicidal thoughts? new trial aims to find out.
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if intravenous (IV) ketamine with Dialectical Behavioural Therapy (DBT) reduces suicidal ideation in individuals with suicidality who have been diagnosed with Borderline Personality Disorder and either Major Depressive Disorder or Bipol…
Phase: PHASE2 • Sponsor: Joshua Rosenblat • Aim: Symptom relief
Last updated Jun 27, 2026 12:29 UTC
-
Ancient herbs take on stroke: new trial tests dengzhan xixin and shengmai
Disease control Not yet recruitingTo integrate large-scale RCT data on clinical symptoms, TCM syndromes, prognosis, and multi-omics profiles, construct a spatiotemporal dynamic network for disease-syndrome evolution of acute ischemic stroke (AIS) in the acute and recovery phases, evaluate the efficacy and safety …
Phase: PHASE2, PHASE3 • Sponsor: Guangdong Provincial Hospital of Traditional Chinese Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
AI could revolutionize heart disease screening in poor regions
Diagnosis Not yet recruitingThe main goal of this project is to see if RADAR (Rapid AI-assisted Detection and Analysis of Rheumatic heart disease), which is a machine and deep-learning AI model, can help make rheumatic heart disease (RHD) screening easier to expand. Specifically, the project will test wheth…
Phase: NA • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Diagnosis
Last updated Jun 27, 2026 12:38 UTC
-
Custom-Made vaccine takes on tough prostate cancer
⭐️ VACCINE ⭐️ ENROLLING_BY_INVITATIONThis phase I study tests a personalized cancer vaccine (Neo-DC) for men with advanced prostate cancer (metastatic castration-resistant prostate cancer, or mCRPC) that has continued to grow despite standard hormone therapies and other treatments. The vaccine is custom-made for ea…
Phase: PHASE1 • Sponsor: Changhai Hospital • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 12:33 UTC
-
Radar + AI spots spine curves without X-Rays
Diagnosis Not yet recruitingScoliosis is a sideways curvature of the spine that often develops during childhood and adolescence. When detected early, scoliosis can be managed effectively with non-invasive approaches such as bracing and physiotherapy, while late detection frequently leads to surgical interve…
Sponsor: Gebze Technical University • Aim: Diagnosis
Last updated Jun 27, 2026 12:34 UTC
-
New drug INV-8989 targets Hard-to-Treat cancers with KRAS G12D mutation
Disease control Recruiting nowThis is a Phase 1 and Phase 2 study to evaluate the safety, tolerability, pharmacokinetics, and preliminary antitumor activity of INV-8989 in patients with advanced solid tumors harboring KRAS G12D mutations.
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Ionova Life Sciences Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Genetic test may guide chemo choice for pancreatic cancer patients
Disease control Not yet recruitingPancreatic ductal adenocarcinoma (PDAC) exhibits significant heterogeneity, making the optimal choice of chemotherapy challenging. While targeted therapies benefit from companion biomarkers, few tools exist to guide the selection of cytotoxic chemotherapy. Transcriptomic signatur…
Phase: PHASE2 • Sponsor: Federation Francophone de Cancerologie Digestive • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New drug combo aims to match standard care in colorectal cancer battle
Disease control Not yet recruitingThis is a randomized, double-blind, phase III clinical trial. The study aims to demonstrate that the treatment regimen of Enlituo® plus FOLFOX is equivalent to that of Erbitux® plus FOLFOX in participants with RAS/BRAF wild-type and MSS/pMMR locally advanced/metastatic colorectal…
Phase: PHASE3 • Sponsor: Taizhou Mabtech Pharmaceutical Co.,Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Artificial intelligence could spot hidden cancer spread before It's too late
Knowledge-focused Not yet recruitingEarly detection and timely intervention of distant metastasis are essential for improving the prognosis of patients with malignant tumors. However, current clinical methods have notable limitations. Conventional imaging can only detect macroscopic metastatic lesions, failing to s…
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:00 UTC
-
Sound waves vs X-Rays: which guides heart stents better?
Disease control Not yet recruitingSTEMI represents the subtype of ACS with the worst prognosis, associated with high mortality and an elevated risk of complications. The use of IVI guidance holds the potential to reduce the incidence of MACE. In previous studies, there has been limited research on intravascular i…
Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a common vitamin a drug tame a deadly immune storm?
Disease control Not yet recruitingThis study is designed to evaluate the safety and preliminary efficacy of all-trans retinoic acid (ATRA) as an initial treatment for patients with active hemophagocytic lymphohistiocytosis (HLH). HLH is a severe hyperinflammatory syndrome caused by excessive activation of immune …
Phase: PHASE2, PHASE3 • Sponsor: Beijing Anzhen Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Placental stem cells injected to help stroke patients recover
Disease control Recruiting nowThis is a Phase I/IIa clinical trial evaluating human placental-derived 3D mesenchymal stem cell (MSC) injection in patients with acute ischemic stroke (AIS). Phase I is a single-dose escalation study to determine the maximum tolerated dose (MTD) and recommended Phase II dose (RP…
Phase: PHASE1, PHASE2 • Sponsor: Chinese PLA General Hospital • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
Engineered immune cells take aim at two cancer targets
Disease control Recruiting nowThe purpose of this study is to assess the feasibility, safety and efficacy of anti-PSMA/CD70 bi-specific CAR-T cell therapy in patients with CD70 and PSMA positive malignancies. Another goal of the study is to learn more about the function of the PSMA/CD70 bi-specific CAR-T cell…
Phase: PHASE1, PHASE2 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Triple-Drug cocktail aims to boost ovarian cancer surgery success
Disease control Recruiting nowThe R0 resection rate in neoadjuvant chemotherapy for advanced ovarian cancer remains below 50%, indicating unmet clinical needs. Tyrosine kinase inhibitors (TKIs) can induce immune microenvironment remodeling and exhibit synergistic effects with immune checkpoint inhibitors. To …
Phase: PHASE2 • Sponsor: Bai-Rong Xia • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
Could a drug help AML patients fight Chemo-Related anemia?
Disease control Recruiting nowThis study aims to explore the feasibility, safety, and preliminary efficacy of rotegcipipone in the treatment of chemotherapy-inducing anemia in AML with a multicenter, prospective, single-arm trial, providing clinical evidence for subsequent clinical development.
Phase: PHASE1, PHASE2 • Sponsor: Guangdong Second Provincial General Hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could CBD oil lift the fog of Treatment-Resistant depression?
Symptom relief Recruiting nowMajor depressive disorder is one of the leading causes of disability worldwide, and a substantial proportion of patients do not achieve adequate improvement with conventional antidepressant treatments. Cannabidiol (CBD), a non-intoxicating cannabinoid derived from Cannabis sativa…
Phase: PHASE1, PHASE2 • Sponsor: Universidade do Sul de Santa Catarina • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC